Spots Global Cancer Trial Database for stereotactic radiation therapy
Every month we try and update this database with for stereotactic radiation therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC | NCT04786093 | Non Small Cell ... | Stereotactic ra... Durvalumab | 18 Years - | University of Texas Southwestern Medical Center | |
SCION: SABR and Checkpoint Inhibition Of NSCLC | NCT04944173 | Non Small Cell ... Carcinoma, Non-... Non-small Cell ... Lung Cancer Lung Cancer Sta... Lung Adenocarci... Lung Squamous C... | Durvalumab Stereotactic Bo... Circulating Tum... | 18 Years - | University of British Columbia | |
Stereotactic Radiation Therapy in Treating Patients With Liver Metastases | NCT00938457 | Unspecified Adu... | stereotactic ra... implanted fiduc... cone-beam compu... | 18 Years - 120 Years | Mayo Clinic | |
A Trial Evaluating Stereotactic Radiotherapy Plus Durvalumab Continuation for Patients With NSCLC Metachronous Oligometastatic Disease Under Durvalumab Consolidation Following Chemoradiation | NCT03955198 | NSCLC | Radiotherapy + ... | 18 Years - | Institut Claudius Regaud | |
Durvalumab (MEDI4736) and Radiosurgery (fSRT vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases | NCT04889066 | Brain Metastase... | Stereotactic Ra... Durvalumab | 18 Years - | University of Texas Southwestern Medical Center | |
Phase II Trial of Stereotactic Radiation Therapy (SRT) Versus SRT Plus Vertebral Augmentation Procedure (VAP) for Vertebral Metastasis | NCT01527292 | Vertebral Metas... | Stereotactic Ra... SRT with Verteb... | 18 Years - | University of Louisville | |
Pancreatic Tumor Cell Vaccine (GVAX), Low Dose Cyclophosphamide, Fractionated Stereotactic Body Radiation Therapy (SBRT), and FOLFIRINOX Chemotherapy in Patients With Resected Adenocarcinoma of the Pancreas | NCT01595321 | Pancreatic Canc... | Cyclophosphamid... PANC 10.05 pcDN... Stereotactic Bo... FOLFIRINOX | 18 Years - 76 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Phase II Trial of Stereotactic Radiation Therapy (SRT) Versus SRT Plus Vertebral Augmentation Procedure (VAP) for Vertebral Metastasis | NCT01527292 | Vertebral Metas... | Stereotactic Ra... SRT with Verteb... | 18 Years - | University of Louisville | |
Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma | NCT04977375 | Glioblastoma Mu... | Pembrolizumab Stereotactic Ra... Surgical Resect... | 18 Years - | Cedars-Sinai Medical Center | |
Comparing Two Forms of Head Immobilization for Stereotactic Radiotherapy | NCT00328510 | Patients Receiv... for Brain Tumor... | GTC frame Thermoplastic f... Stereotactic ra... | 18 Years - | Thomas Jefferson University | |
Stereotactic Radiotherapy for Cerebral Metastases With Recent Hemorrhagic Signal | NCT03696680 | Hemorrhagic Bra... | FSRT Stereotact... | 18 Years - | Centre Francois Baclesse | |
Stereotactic Radiotherapy for Cerebral Metastases With Recent Hemorrhagic Signal | NCT03696680 | Hemorrhagic Bra... | FSRT Stereotact... | 18 Years - | Centre Francois Baclesse |